1.21 (-%)
As of Nov 20, 2024
Source:
Alx Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 immune checkpoint and bridge the innate and adaptive immune system.
| Country | United States |
| Headquarters | south san francisco, california |
| Phone Number | 650-466-7125 |
| Industry | manufacturing |
| CEO | Jason Lettmann |
| Website | alxoncology.com |